Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Construction in Progress (2016 - 2024)

Historic Construction in Progress for Heron Therapeutics (HRTX) over the last 11 years, with Q4 2024 value amounting to $2.6 million.

  • Heron Therapeutics' Construction in Progress fell 5873.02% to $2.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.6 million, marking a year-over-year decrease of 5873.02%. This contributed to the annual value of $2.6 million for FY2024, which is 5873.02% down from last year.
  • According to the latest figures from Q4 2024, Heron Therapeutics' Construction in Progress is $2.6 million, which was down 5873.02% from $6.3 million recorded in Q4 2023.
  • Heron Therapeutics' 5-year Construction in Progress high stood at $15.9 million for Q4 2021, and its period low was $2.6 million during Q4 2024.
  • For the 5-year period, Heron Therapeutics' Construction in Progress averaged around $8.9 million, with its median value being $6.3 million (2023).
  • As far as peak fluctuations go, Heron Therapeutics' Construction in Progress crashed by 6603.77% in 2022, and later soared by 1666.67% in 2023.
  • Over the past 5 years, Heron Therapeutics' Construction in Progress (Quarter) stood at $14.1 million in 2020, then rose by 12.77% to $15.9 million in 2021, then tumbled by 66.04% to $5.4 million in 2022, then grew by 16.67% to $6.3 million in 2023, then tumbled by 58.73% to $2.6 million in 2024.
  • Its Construction in Progress was $2.6 million in Q4 2024, compared to $6.3 million in Q4 2023 and $5.4 million in Q4 2022.